RAEDYONT Trademark

Trademark Overview


On Monday, October 25, 2021, a trademark application was filed for RAEDYONT with the United States Patent and Trademark Office. The USPTO has given the RAEDYONT trademark a serial number of 97090507. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, October 14, 2024. This trademark is owned by Novartis AG. The RAEDYONT trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of h...
raedyont

General Information


Serial Number97090507
Word MarkRAEDYONT
Filing DateMonday, October 25, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, October 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2023

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Translation of Words in MarkThe wording "RAEDYONT" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4002
CH

Trademark Events


Event DateEvent Description
Tuesday, August 2, 2022NON-FINAL ACTION E-MAILED
Thursday, October 28, 2021NEW APPLICATION ENTERED
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 2, 2022ASSIGNED TO EXAMINER
Tuesday, August 2, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 13, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 13, 2023SOU EXTENSION 1 FILED
Friday, October 13, 2023SOU EXTENSION 1 GRANTED
Saturday, March 30, 2024SOU EXTENSION 2 GRANTED
Saturday, March 30, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 14, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 14, 2024SOU EXTENSION 3 GRANTED
Monday, October 14, 2024SOU EXTENSION 3 FILED
Tuesday, April 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 30, 2024SOU EXTENSION 2 FILED